Devi B C R, Tang T S, Corbex M
Department of Radiotherapy and Oncology, Sarawak General Hospital, Sarawak, Malaysia.
Ann Oncol. 2007 Jul;18(7):1172-6. doi: 10.1093/annonc/mdm105. Epub 2007 Apr 13.
The registry of the Oncology Departmental in Sarawak General Hospital showed that 79% of nasopharyngeal, 77% of breast and 70% of cervix cancer patients were diagnosed at an advanced stage (stages III and IV) for year 1993. Hence, a low cost Early Cancer Surveillance Program was started in 1994, with the intent of downstaging these three most common cancers in Sarawak.
The program consisted of (i) training health staff in hospital and rural clinics to improve their skills in early cancer detection, (ii) raising public awareness through pamphlets, posters and sensitization by health staff.
Data analysis revealed that the program achieved downstaging in two of the cancers. Breast cancer in stage III and IV was reduced from 60% (1994) to 35% (1998) (P < 0.0001) and cervical cancer in stage III and IV from 60% (1994) to 26% (1998) (P < 0.0001). No reduction was observed for nasopharyngeal cancer at 88% (1994) to 91% (1998).
The overall cost of this program was <US$34 000. It is cost-effective and easy to implement and would be a valuable alternative in countries where majority of the tumors are found in late stage (III and IV) where screening programs meet important difficulties. Our data analyses revealed important shortcomings in the PAP smear screening program where inadequate groups of women were screened. It resulted in a pick up rate of only 5% of the cases. This finding confirmed the need for the simple and complementary downstaging approach.
砂拉越总医院肿瘤科登记数据显示,1993年,79%的鼻咽癌患者、77%的乳腺癌患者和70%的宫颈癌患者在确诊时已处于晚期(III期和IV期)。因此,1994年启动了一项低成本的早期癌症监测项目,旨在降低砂拉越这三种最常见癌症的分期。
该项目包括:(i)培训医院和农村诊所的医护人员,以提高他们早期癌症检测的技能;(ii)通过宣传册、海报以及医护人员的宣传提高公众意识。
数据分析显示,该项目在其中两种癌症中实现了分期降低。III期和IV期乳腺癌从1994年的60%降至1998年的35%(P<0.0001),III期和IV期宫颈癌从1994年的60%降至1998年的26%(P<0.0001)。鼻咽癌的分期从1994年的88%降至1998年的91%,未出现降低。
该项目的总成本<3.4万美元。它具有成本效益且易于实施,对于大多数肿瘤在晚期(III期和IV期)发现、筛查项目面临重大困难的国家来说,将是一种有价值的选择。我们的数据分析揭示了巴氏涂片筛查项目存在的重要缺陷,即接受筛查的女性群体不足。这导致病例检出率仅为5%。这一发现证实了采用简单且互补的分期降低方法的必要性。